Video Experimental Relacionado

Updated: Sep 10, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Riesgo de cáncer de endometrio entre sobrevivientes de cáncer de mama en Japón: un estudio de cohorte emparejado

Chitose Kawamura^1,2,3, Krishnan Bhaskaran⁴, Takaaki Konishi^5,6

¹Department of Health Services Research, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.

Breast cancer (Tokyo, Japan)

|August 27, 2025

Resumen

Las sobrevivientes de cáncer de mama en Japón enfrentan un riesgo significativamente mayor de cáncer de endometrio. Este aumento del riesgo es particularmente pronunciado en las personas tratadas con tamoxifeno o que no reciben tratamiento endocrino.

Área de la Ciencia:

En el campo de la oncología
Ginecología
Epidemiología

Sus antecedentes:

Las sobrevivientes de cáncer de mama (CC) pueden tener un riesgo elevado de cáncer de endometrio debido a factores de riesgo compartidos y al uso de tamoxifeno.
El riesgo específico en Japón y para diferentes regímenes de terapia endocrina entre los sobrevivientes de BC sigue sin estar claro.

Objetivo del estudio:

Investigar el riesgo de cáncer de endometrio en sobrevivientes de cáncer de mama en comparación con las mujeres sin antecedentes de cáncer de mama en Japón.
Para analizar el riesgo de cáncer endometrial basado en tratamientos específicos de terapia endocrina, incluidos el tamoxifeno y los inhibidores de la aromatasa (IA).

Principales métodos:

Se realizó un estudio de cohorte emparejado utilizando la base de datos de reclamaciones de JMDC en Japón (2005-2019).
23.729 sobrevivientes de BC fueron emparejados 1:4 con 95.659 mujeres sin BC por edad y entrada en la base de datos.
El riesgo de cáncer de endometrio se evaluó utilizando regresión de Cox estratificada y no estratificada, con un seguimiento que comenzó un año después de la coincidencia.

Principales resultados:

Las sobrevivientes de BC mostraron un riesgo significativamente mayor de cáncer de endometrio (ratio de riesgo ajustado [aHR] = 7,71) en comparación con las mujeres sin BC.
Entre los tratamientos endocrinos, el uso de tamoxifeno se asoció con el riesgo más alto (aHR = 5,67), seguido de la ausencia de tratamiento endocrino (aHR = 3,56).
El uso de inhibidores de la aromatasa (IA) mostró una tendencia hacia un aumento del riesgo (aHR = 2.17), pero no fue estadísticamente significativo en este análisis.

Conclusiones:

Las sobrevivientes de cáncer de mama en Japón tienen un riesgo sustancialmente mayor de desarrollar cáncer de endometrio.
La terapia con tamoxifeno y la falta de terapia endocrina se asociaron con un mayor riesgo de cáncer de endometrio entre las sobrevivientes de BC.
Puede ser necesaria una investigación adicional para aclarar el riesgo asociado con la terapia de IA en esta población.

Palabras clave:

Inhibidor de la aromatasa Cáncer de mama Sobreviviente de cáncer Cáncer de endometrio El tamoxifeno

Más Videos Relacionados

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Videos de Conceptos Relacionados

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Bias in Epidemiological Studies

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

Relative Risk

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...

Study Designs in Epidemiology

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...